Home/Pipeline/Sitagliptin Intermediate

Sitagliptin Intermediate

Type 2 Diabetes

CommercialActive

Key Facts

Indication

Type 2 Diabetes

Phase

Commercial

Status

Active

Company

AR Life Science

About AR Life Science

Indian API manufacturer delivering GMP‑certified small‑molecule intermediates for global pharma.

View full company profile

Therapeutic Areas

Cardiovascular Oncology Diabetes Urology Psychiatry Anti-coagulant

Other Type 2 Diabetes Drugs

Drug	Company	Phase	Status
Diabetes Management Gel	Gelteq Limited	Formulation Development	Active
Tolimidone	Biodexa Pharmaceuticals	Phase 2	Acquired Asset
Generic Semaglutide Injection (Obeda)	Dr. Reddy's Laboratories	Approved	Launched in India
BioChaperone® Lispro	Adocia	Phase 3	Active
BioChaperone® Combo (Insulin Glargine / Lixisenatide)	Adocia	Phase 2	Active
Metformin API	USV Biologics Division	Commercial	Active
Empagliflozin	Azico Biophore	Commercial	Active
AJN003 (LuCI™)	AltrixBio	Pre-clinical	Advancing to Phase 1 (planned 2026)
Sitagliptin Phosphate Polymorph	Morepen Laboratories	Pre‑clinical	Active
Hepatic Denervation for Type 2 Diabetes	Metavention	Feasibility	Active
MVD-1 (SANA)	Eolo Pharma	Discovery	Active
Type 2 Diabetes Management	iWel	Development	Active